Qi Sun, Diming Liu, Weiwei Cui, Huimin Cheng, Lixia Huang, Ruihao Zhang, Junlian Gu, Shuo Liu, Xiao Zhuang, Yi Lu, Bo Chu & Jian Li. (2023) Cholesterol mediated ferroptosis suppression reveals essential roles of Coenzyme Q and squalene. Communications Biology 6:1.
Crossref
Anna Giménez-Palomo, Seetal Dodd, Gerard Anmella, Andre F. Carvalho, Giselli Scaini, Joao Quevedo, Isabella Pacchiarotti, Eduard Vieta & Michael Berk. (2021) The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment. Frontiers in Psychiatry 12.
Crossref
Jessica R. Morrice, Michael Kuo & Christopher A. Shaw. 2021. Spectrums of Amyotrophic Lateral Sclerosis. Spectrums of Amyotrophic Lateral Sclerosis
181
199
.
Ahlam Alhusaini, Iman H. Hasan, Bashayer Alrumayyan, Marwa Alesikri, Khansa Alanazi, Rawan Almasoud & Sarah Almarshad. (2020) Neuroprotective efficacy of nano‐CoQ against propionic acid toxicity in rats: Role of BDNF and CREB protein expressions. Journal of Biochemical and Molecular Toxicology 34:4.
Crossref
Margaux Teil, Marie-Laure Arotcarena, Emilie Faggiani, Florent Laferriere, Erwan Bezard & Benjamin Dehay. (2020) Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts. Biomolecules 10:3, pages 391.
Crossref
Guillermo López-Lluch. 2017. Nutrition and Functional Foods for Healthy Aging. Nutrition and Functional Foods for Healthy Aging
307
316
.
Giselli Scaini, Gislaine T. Rezin, Andre F. Carvalho, Emilio L. Streck, Michael Berk & João Quevedo. (2016) Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications. Neuroscience & Biobehavioral Reviews 68, pages 694-713.
Crossref
Dennis Ma, Kyle Stokes, Kevinjeet Mahngar, Danijela Domazet-Damjanov, Marianna Sikorska & Siyaram Pandey. (2014) Inhibition of stress induced premature senescence in presenilin-1 mutated cells with water soluble Coenzyme Q10. Mitochondrion 17, pages 106-115.
Crossref
Deepak M. Kasote, Mahabaleshwar V. Hegde & Surendra S. Katyare. (2013) Mitochondrial dysfunction in psychiatric and neurological diseases: Cause(s), consequence(s), and implications of antioxidant therapy. BioFactors 39:4, pages 392-406.
Crossref
Sushruta Koppula, Hemant Kumar, Sandeep Vasant More, Byung Wook Kim, In Su Kim & Dong-Kug Choi. (2012) Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease. International Journal of Molecular Sciences 13:8, pages 10608-10629.
Crossref
K. Gayathri, KS Jayachandran, Hannah R VasanthiG. Victor Rajamanickam. (2010) Cardioprotective effect of lemon grass as evidenced by biochemical and histopathological changes in experimentally induced cardiotoxicity. Human & Experimental Toxicology 30:8, pages 1073-1082.
Crossref
K. HAMRE. (2011) Metabolism, interactions, requirements and functions of vitamin E in fish. Aquaculture Nutrition 17:1, pages 98-115.
Crossref
Ingrid Wiswedel, Wolfgang Augustin, Sven Quist, Harald Gollnick & Andreas Gardemann. 2011. Studies on Experimental Models. Studies on Experimental Models
441
465
.
Katharina Faust, Stephan Gehrke, Yufeng Yang, Lichuan Yang, M Flint Beal & Bingwei Lu. (2009) Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease. BMC Neuroscience 10:1.
Crossref
Barkha P. Patel & Mazen J. Hamadeh. (2009) Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis. Clinical Nutrition 28:6, pages 604-617.
Crossref
Lichuan Yang, Noel Y. Calingasan, Elizabeth J. Wille, Kerry Cormier, Karen Smith, Robert J. Ferrante & M. Flint Beal. (2009)
Combination therapy with Coenzyme Q
10
and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases
. Journal of Neurochemistry 109:5, pages 1427-1439.
Crossref
Noriko YamaguchiKaori NakamuraYoshihiro OgumaSho FujiwaraMichihito TakabeAkira SonoTsuneshirou Kawasaki, Kazumasa Otsubo & Koichi Wakigawa. (2009) Genotoxicity studies of ubidecarenone (coenzyme Q10) manufactured by bacteria fermentation. The Journal of Toxicological Sciences 34:4, pages 389-397.
Crossref
Hiroshi Kubo, Kenji Fujii, Taizo Kawabe, Shuka Matsumoto, Hideyuki Kishida & Kazunori Hosoe. (2008) Food content of ubiquinol-10 and ubiquinone-10 in the Japanese diet. Journal of Food Composition and Analysis 21:3, pages 199-210.
Crossref
Carine Cleren, Lichuan Yang, Beverly Lorenzo, Noel Y. Calingasan, Andrew Schomer, Anthony Sireci, Elizabeth J. Wille & M. Flint Beal. (2008) Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism. Journal of Neurochemistry 104:6, pages 1613-1621.
Crossref
Mitsuaki Kitano, Dai Watanabe, Shigehito Oda, Hiroshi Kubo, Hideyuki Kishida, Kenji Fujii, Mikio Kitahara & Kazunori Hosoe. (2008) Subchronic Oral Toxicity of Ubiquinol in Rats and Dogs. International Journal of Toxicology 27:2, pages 189-215.
Crossref
Mitsuaki Kitano, Fukutaro Mizuhashi, Hiroshi Kubo, Hideyuki Kishida, Kenji Fujii, Mikio Kitahara & Kazunori Hosoe. (2016) Evaluation of the Mutagenic and Genotoxic Potential of Ubiquinol. International Journal of Toxicology 26:6, pages 533-544.
Crossref
Kazunori Hosoe, Mitsuaki Kitano, Hideyuki Kishida, Hiroshi Kubo, Kenji Fujii & Mikio Kitahara. (2007) Study on safety and bioavailability of ubiquinol (Kaneka QH™) after single and 4-week multiple oral administration to healthy volunteers. Regulatory Toxicology and Pharmacology 47:1, pages 19-28.
Crossref
. (2007)
A randomized clinical trial of coenzyme Q
10
and GPI-1485 in early Parkinson disease
. Neurology 68:1, pages 20-28.
Crossref
Kumiko HONDASayumi TOMINAGATakafumi OSHIKATAKouichi KAMIYAMasao HAMAMURATsuneshirou KAWASAKI & Kouichi WAKIGAWA. (2007) THIRTEEN-WEEK REPEATED DOSE ORAL TOXICITY STUDY OF COENZYME Q10 IN RATS. The Journal of Toxicological Sciences 32:4, pages 437-448.
Crossref
Karen M. Smith, Samantha Matson, Wayne R. Matson, Kerry Cormier, Steven J. Del Signore, Sean W. Hagerty, Edward C. Stack, Hoon Ryu & Robert J. Ferrante. (2006) Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1762:6, pages 616-626.
Crossref
M. Kitano, K. Hosoe, N. Fukutomi, T. Hidaka, R. Ohta, K. Yamakage & T. Hara. (2006) Evaluation of the mutagenic potential of ubidecarenone using three short-term assays. Food and Chemical Toxicology 44:3, pages 364-370.
Crossref
Katrin Staniek, Thomas Rosenau, Wolfgang Gregor, Hans Nohl & Lars Gille. (2005) The protection of bioenergetic functions in mitochondria by new synthetic chromanols. Biochemical Pharmacology 70:9, pages 1361-1370.
Crossref
Jiali Tang, Cameron Faustman, Thomas A. Hoagland, Richard A. Mancini, Mark Seyfert & Melvin C. Hunt. (2005) Interactions between Mitochondrial Lipid Oxidation and Oxymyoglobin Oxidation and the Effects of Vitamin E. Journal of Agricultural and Food Chemistry 53:15, pages 6073-6079.
Crossref
Clifford W. Shults. (2005) Therapeutic role of coenzyme Q10 in Parkinson's disease. Pharmacology & Therapeutics 107:1, pages 120-130.
Crossref
David A. Groneberg, Birgit Kindermann, Martin Althammer, Maja Klapper, Jürgen Vormann, Gian P. Littarru & Frank Döring. (2005) Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. The International Journal of Biochemistry & Cell Biology 37:6, pages 1208-1218.
Crossref
M. Kitano, K. Hosoe, N. Fukutomi, T. Hidaka, N. Imai & M. Kawabe. (2004) 28-Day repeated dose toxicity study of dried microorganism in rats. Food and Chemical Toxicology 42:11, pages 1817-1824.
Crossref
M. Flint Beal & Robert J. Ferrante. (2004) Experimental therapeutics in transgenic mouse models of Huntington's disease. Nature Reviews Neuroscience 5:5, pages 373-384.
Crossref
Christine Rauca, Ingrid Wiswedel, Renate Zerbe, Gerburg Keilhoff & Manfred Krug. (2004) The role of superoxide dismutase and α-tocopherol in the development of seizures and kindling induced by pentylenetetrazol - influence of the radical scavenger α-phenyl-N-tert-butyl nitrone. Brain Research 1009:1-2, pages 203-212.
Crossref
Andrea Ernst, Alexandra Stolzing, Grit Sandig & Tilman Grune. (2004) Antioxidants effectively prevent oxidation-induced protein damage in OLN 93 cells. Archives of Biochemistry and Biophysics 421:1, pages 54-60.
Crossref
M.Flint Beal. 2004. Quinones and Quinone Enzymes, Part B. Quinones and Quinone Enzymes, Part B
473
487
.
Ching Kuang Chow. 2004. Quinones and Quinone Enzymes, Part B. Quinones and Quinone Enzymes, Part B
105
112
.
M. FLINT BEAL. (2006) Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease. Annals of the New York Academy of Sciences 991:1, pages 120-131.
Crossref
Vladimir Gogvadze, Patrick B Walter & Bruce N Ames. (2003) The role of Fe2+-induced lipid peroxidation in the initiation of the mitochondrial permeability transition. Archives of Biochemistry and Biophysics 414:2, pages 255-260.
Crossref
Catrina Colomé, Rafael Artuch, Maria-Antònia Vilaseca, Cristina Sierra, Núria Brandi, Nilo Lambruschini, Francisco J Cambra & Jaume Campistol. (2003) Lipophilic antioxidants in patients with phenylketonuria,,. The American Journal of Clinical Nutrition 77:1, pages 185-188.
Crossref
Marianna Sikorska, Henryk Borowy-Borowski, Bogdan Zurakowski & P. Roy Walker. (2003)
Derivatised α-tocopherol as α CoQ
10
carrier in a novel water-soluble formulation
. BioFactors 18:1-4, pages 173-183.
Crossref
M. Flint Beal & Clifford W. Shults. (2003)
Effects of Coenzyme Q
10
in Huntington's disease and early Parkinson's disease
. BioFactors 18:1-4, pages 153-161.
Crossref
M. Flint Beal. (2003) Bioenergetic approaches for neuroprotection in Parkinson's disease. Annals of Neurology 53:S3, pages S39-S48.
Crossref
M. F. Beal. 2002. CNS Neuroprotection. CNS Neuroprotection
95
113
.
Catherine Crone, Geoff Gabriel & Thomas N. Wise. (2001) Non-Herbal Nutritional Supplements—The Next Wave: A Comprehensive Review of Risks and Benefits for the C-L Psychiatrist. Psychosomatics 42:4, pages 285-299.
Crossref
Yossi Gilgun-Sherki, Eldad Melamed & Daniel Offen. (2001) Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40:8, pages 959-975.
Crossref
Mark A. Tarnopolsky & M. Flint Beal. (2001) Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Annals of Neurology 49:5, pages 561-574.
Crossref
Wissam H. Ibrahim, Ching K. Chow, Hemmi N. Bhagavan & Raj K. Chopra. (2000) Dietary Coenzyme Q10 and Vitamin E Alter the Status of These Compounds in Rat Tissues and Mitochondria. The Journal of Nutrition 130:9, pages 2343-2348.
Crossref
M.Flint Beal. (2000) Energetics in the pathogenesis of neurodegenerative diseases. Trends in Neurosciences 23:7, pages 298-304.
Crossref
Guy Rousseau, Marc Véronneau, Christine DesRosiers & France Varin. (2000) Effects of lovastatin and pravastatin on ubiquinone and 4-hydroxynonenal tissue levels in the hypercholesterolemic hamster. Current Therapeutic Research 60:2, pages 87-104.
Crossref
M. Flint Beal. (1999)
Coenzyme Q
10
administration and its potential for treatment of neurodegenerative diseases
. BioFactors 9:2-4, pages 261-266.
Crossref
Russell T. Matthews, Lichuan Yang, Susan Browne, Myong Baik & M. Flint Beal. (1998)
Coenzyme Q
10
administration increases brain mitochondrial concentrations and exerts neuroprotective effects
. Proceedings of the National Academy of Sciences 95:15, pages 8892-8897.
Crossref
Thomas Reinheckel, Barbara Nedelev, Juliane Prause, Wolfgang Augustin, Hans-Ulrich Schulz, Hans Lippert & Walter Halangk. (1998) Occurrence of Oxidatively Modified Proteins. Free Radical Biology and Medicine 24:3, pages 393-400.
Crossref
Valerian E. Kagan, Yulia Y. Tyurina & Eric Witt. 1998. Fat-Soluble Vitamins. Fat-Soluble Vitamins
491
507
.
M.Flint Beal & Russell T. Matthews. (1997) Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases. Molecular Aspects of Medicine 18, pages 169-179.
Crossref
Wolfgang Augustin, Ingrid Wiswedel, Heiko Noack, Thomas Reinheckel & Olaf Reichelt. 1997. Detection of Mitochondrial Diseases. Detection of Mitochondrial Diseases
199
205
.
Okezie I. Aruoma. (1996) Characterization of drugs as antioxidant prophylactics. Free Radical Biology and Medicine 20:5, pages 675-705.
Crossref
Patrik Forsmark-AndrÉe, Gustav Dallner & Lars Ernster. (1995) Endogenous ubiquinol prevents protein modification accompanying lipid peroxidation in beef heart submitochondrial particles. Free Radical Biology and Medicine 19:6, pages 749-757.
Crossref
Thomas Reinheckel, Ingrid Wiswedel, Heiko Noack & Wolfgang Augustin. (1995) Electrophoretic evidence for the impairment of complexes of the respiratory chain during iron/ascorbate induced peroxidation in isolated rat liver mitochondria. Biochimica et Biophysica Acta (BBA) - Biomembranes 1239:1, pages 45-50.
Crossref
M. Flint Beal. (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Annals of Neurology 38:3, pages 357-366.
Crossref